Login / Signup

Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.

Jorge B Cannata-AndíaBeatriz Martín-CarroJulia Martín-VírgalaJavier Rodríguez-CarrioJosé Joaquín Bande-FernándezCristina Alonso-MontesNatalia Carrillo-López
Published in: Calcified tissue international (2020)
The key players of the chronic kidney disease-mineral and bone disorders (CKD-MBD) are calcium, phosphate, PTH, FGF23, and the vitamin D hormonal system. The progressive reduction of kidney function greatly modifies the tightly interrelated mechanisms that control these parameters. As a result, important changes occur in the bone and mineral hormonal axis, leading to changes in bone turnover with relevant consequences in clinical outcomes, such as decrease in bone mass with increased bone fragility and bone fractures and increased vascular and valvular calcification, also with great impact in the cardiovascular outcomes. So far, the knowledge of the mineral and bone disorders in CKD and the increased variety of efficacious therapies should lead to a better prevention and management of CKD-MBD.
Keyphrases
  • chronic kidney disease
  • bone mineral density
  • soft tissue
  • bone loss
  • end stage renal disease
  • bone regeneration
  • multiple sclerosis
  • healthcare
  • type diabetes
  • metabolic syndrome
  • atrial fibrillation
  • aortic valve